Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR+330.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+330.6%/yr
vs -76.4%/yr prior
Acceleration
+407.0pp
Accelerating
Percentile
P43
Within normal range
vs 3Y Ago
79.8x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 14.99% |
| 2024 | 30.76% |
| 2023 | -1.45% |
| 2022 | 0.19% |
| 2021 | 14.44% |
| 2020 | -19.62% |
| 2019 | 15.67% |
| 2018 | 60.49% |
| 2017 | 40.25% |
| 2016 | 40.90% |